- CSR Summary Not Yet Available
- NCT Number Not Available
- Primary Citation Not Yet Available
- Data Specification Not Available
You are not logged in.
Please login to continue selecting trials.
Generic NameTrabectedinProduct NameYONDELIS®Therapeutic AreaCancers and Other NeoplasmsEnrollment34% FemaleN/A% WhiteN/A
Product ClassAntineoplastic AgentsSponsor Protocol NumberET-B-017-99Data PartnerJohnson & JohnsonCondition StudiedSarcomaMean/Median Age (Years)N/A
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available
Please note: individual participant-level data are not available for this trial. Only the annotated CRF, protocol, statistical analysis plan, and full clinical study report are available.